Testosterone for Testicular Hypogonadism
What You Need to Know Before You Apply
What is the purpose of this trial?
A Phase 4, multi-center, open-label, single-arm 24-hour Ambulatory Blood Pressure Monitoring (ABPM) study of Testosterone Cypionate Injection in Hypogonadal Men to assess change in 24-hour ambulatory blood pressure from Baseline to End of Treatment
Are You a Good Fit for This Trial?
Men aged 18-75 with low testosterone levels (below specific thresholds) and a BMI between 17 to less than 40. They must have stable blood pressure, not be on high doses of glucocorticoids, and either haven't taken testosterone therapy or have stopped it long enough for a washout period. The study is not suitable for those who don't meet these criteria.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Testosterone Cypionate Injection and undergo 24-hour Ambulatory Blood Pressure Monitoring
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Testosterone Cypionate Injection
Trial Overview
The trial tests the effects of Testosterone Cypionate Injection on blood pressure in men with low testosterone. It's an open-label study where all participants receive the injection and their blood pressure is monitored over 24 hours to see any changes from before treatment.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
Azurity Pharmaceuticals
Lead Sponsor
CBCC Global Research
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.